Phio Pharmaceutical

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHIO and other ETFs, options, and stocks.

About PHIO

Phio Pharmaceuticals Corp. is a biotechnology company engaged in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. 

CEO
Geert Cauwenbergh, PhD
CEOGeert Cauwenbergh, PhD
Employees
12
Employees12
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
2011
Founded2011
Employees
12
Employees12

PHIO Key Statistics

Market cap
5.47M
Market cap5.47M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
66.02K
Average volume66.02K
High today
$0.42
High today$0.42
Low today
$0.40
Low today$0.40
Open price
$0.42
Open price$0.42
Volume
6.79K
Volume6.79K
52 Week high
$2.42
52 Week high$2.42
52 Week low
$0.39
52 Week low$0.39

PHIO Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 21, After Hours
ActualExpected Mar 21, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.